Word

IDS I20

Status

Registered

Status Code

700

Status Date

Tuesday, December 25, 2018

Serial Number

79225752

Registration Number

5635057

Registration Date

Tuesday, December 25, 2018

Mark Type

5000

Filing Date

Monday, October 23, 2017

Published for Opposition

Tuesday, October 9, 2018

Trademark Owner History

Immunodiagnostic Systems Limited - Original Registrant

Classifications

9 Instruments, namely, scientific instruments, namely, automated analyzers for testing and analyzing chemical and biological substances for the presence, absence or quantity of biological analytes or target chemicals, or instruments using automated detection methods for detecting and identifying chemical and biological substances, not for medical purposes, for testing, processing or detecting biological samples; computer software for use in analyzing and managing biological data

5 Reagents for use in diagnostic tests, namely, diagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical purposes; chemical diagnostic reagents for medical use; diagnostic preparations, namely, diagnostic reagents for medical use; diagnostic testing materials, namely, immunoassays and chemistry tests for measuring analytes for use in diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical use; reagents for use in diagnostic tests; chemical preparations for testing blood for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry for medical purposes; diagnostic reagents for medical use for sale in kit form, namely diagnostic kits comprised primarily of medical diagnostic reagents for testing of bodily fluids for use in disease detection, namely, diseases and disorders in the areas of endocrinology, clinical chemistry, autoimmunity, infectious diseases, allergy, hemostasis, coagulation, hematology, immunology, therapeutic drug monitoring, oncology markers, other biomarkers, and immunochemistry

1 Diagnostic reagents for scientific or research use; diagnostic reagents for in vitro use other than medical, namely, research or scientific investigation in the areas of immunochemistry, immunology, clinical chemistry, biochemistry, microbiology, hematology, and hemostasis; diagnostic test reagents, chemical and biochemical reagents, and preparations for determining the presence or concentration of an analyte for clinical, scientific or research purposes; diagnostic preparations for scientific or research use; assays and reagents for research purposes; biological and biochemical reagents, used for non-medical purposes, namely, for research and commercial use in the nature of biochemical or biological analysis

10 Medical diagnostic apparatus for medical purposes, namely, diagnostic instruments for medical use in immunoassay and clinical chemistry testing such as electromagnetic medical diagnostic imaging apparatus; medical diagnostic testing instruments for use in immunoassay medical procedures, namely, medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; medical diagnostic instruments, namely, medical instrument for cardiovascular diagnostics; blood testing apparatus

The mark consists of the literal elements "IDS I20" represented in stylized font wherein the letters "IDS" and "I" appear in lower font in the color gray, and the dots over each letter "I" appear in red. The numbers "2" and "0" appear in gray.
IDS ITWO0
The color(s) red and gray is/are claimed as a feature of the mark.

Trademark Events

Dec 25, 2023

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 6, 2023

Teas Change Of Correspondence Received

Oct 6, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Oct 6, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Oct 6, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 6, 2023

Teas Change Of Owner Address Received

Apr 26, 2019

Final Decision Transaction Processed By Ib

Apr 9, 2019

Final Disposition Notice Sent To Ib

Apr 9, 2019

Final Disposition Processed

Mar 25, 2019

Final Disposition Notice Created, To Be Sent To Ib

Dec 25, 2018

Registered-Principal Register

Oct 9, 2018

Official Gazette Publication Confirmation E-Mailed

Oct 9, 2018

Published For Opposition

Oct 6, 2018

Notification Processed By Ib

Sep 19, 2018

Notification Of Possible Opposition Sent To Ib

Sep 19, 2018

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Sep 19, 2018

Notification Of Notice Of Publication E-Mailed

Sep 4, 2018

Assigned To Lie

Aug 20, 2018

Approved For Pub - Principal Register

Jul 31, 2018

Teas/Email Correspondence Entered

Jul 30, 2018

Correspondence Received In Law Office

Jul 30, 2018

Teas Response To Office Action Received

Mar 2, 2018

Refusal Processed By Ib

Feb 14, 2018

Non-Final Action Mailed - Refusal Sent To Ib

Feb 14, 2018

Refusal Processed By Mpu

Feb 9, 2018

Application Filing Receipt Mailed

Feb 8, 2018

Non-Final Action (Ib Refusal) Prepared For Review

Feb 7, 2018

Non-Final Action Written

Feb 5, 2018

Assigned To Examiner

Feb 5, 2018

New Application Office Supplied Data Entered

Feb 1, 2018

Sn Assigned For Sect 66a Appl From Ib